New Report: Quality Adjusted Life Years (QALY) Methodology Discriminates Against Older Americans, Threatens to Deny Seniors Access to Life-Saving Care

Share on Facebook
Share on Twitter
Share on
LinkedIn
+

Pioneer Institute Asserts that with Older Americans More Vulnerable during the COVID-19 Pandemic, All Health Plans Should Avoid Using the QALY Methodology When Assessing the Value of Care for Older Patients

Boston, MA (April 2, 2020) – Today, Pioneer Institute released a new report, Quality Adjusted Life Years (QALY): The Threat to Older Americans, which examines how the QALY methodology to determine drug treatment value threatens to discriminate against older adults by placing a lower value on treatments that would extend the life of or improve quality of life for older patients.  This clear bias against providing access to therapies to seniors comes at a critical and especially vulnerable time for older Americans given the coronavirus disease (COVID-19).  Authored by Pioneer Institute Visiting Fellow in Life Sciences, Dr. William Smith, the report concludes that the QALY methodology, utilized most notably by the Institute for Clinical and Economic Review (ICER), has the potential to deny seniors’ access to high-quality, life-saving treatments.

QALYs rate medical treatments according to their ability to extend life and to improve the quality of life. Pioneer Institute’s report explains how the QALY method of assessing the value of medicines is inherently discriminatory and ageist, as it will consistently rate treatments for older Americans as less cost-effective than for younger people. The report explains:

“Treatments that provide more ‘life years’ will be rated as ‘more effective’ under QALY, which superficially sounds commonsensical unless you realize that this standard will, by definition, be used to argue that drugs for senior citizens with shorter life expectancies will be rated lower than drugs for younger people.” (Pg. 1)

Pioneer Institute’s report explores how the use of the QALY methodology would specifically affect those receiving palliative care. While palliative care treatments may significantly improve the quality of life for patients with a serious or life-limiting condition, they often do not extend it. The report illustrates how the QALY methodology contains inherent bias when applied to palliative care:

“Palliative care highlights the problem of using the QALY methodology generally: not every decision made in healthcare should be justified solely based on cost-effectiveness. Human beings make value judgments about how to care for their fellow human beings…These formulas themselves are based upon certain value judgments that human life is less valuable than many Americans think.” (Pg. 3)

Pioneer Institute’s report warns that federal policy proposals that consider the use of QALYs to make treatment access decisions, such as “Medicare for All,” could have disastrous consequences for American seniors. The report concludes:

“Senior citizens who become enrolled in a Medicare for All plan and are then denied valuable treatments based upon a QALY cost-effectiveness review might not share ICER’s view on the value of QALYs. Not only is ICER’s modeling of the value of longevity flawed, they also de-value treatments such as palliative care that are extremely important to older Americans and their families but may not increase longevity.” (Pg. 3)

Read a one-page fact sheet on the report.

###

About the Author

William S. Smith is Visiting Fellow in Life Sciences at Pioneer Institute.  He has 25 years of experience in government and in corporate roles, including as vice president of public affairs and policy at Pfizer, and as a consultant to major pharmaceutical, biotechnology and medical device companies. He held senior staff positions for the Republican House leadership on Capitol Hill, the White House, and in the Massachusetts Governor’s office. He is affiliated as research fellow and managing director with the Center for the Study of Statesmanship at The Catholic University of America (CUA), where he earned his PhD.

About Pioneer Institute

Pioneer Institute is an independent, non-partisan, privately funded research organization that seeks to improve the quality of life in Massachusetts through civic discourse and intellectually rigorous, data-driven public policy solutions based on free market principles, individual liberty and responsibility, and the ideal of effective, limited and accountable government.

Get Updates On Our Life Sciences Work!

Related Posts:

Aurora Institute’s Susan Patrick on Digital Learning Lessons from COVID-19

This week on “The Learning Curve," co-hosts Gerard Robinson and Cara Candal talk with Susan Patrick, the President and CEO of Aurora Institute and co-founder of CompetencyWorks. Susan shares observations about the long-term implications of the COVID-19 pandemic for American K-12 education, and the prospects for expanding digital learning.

Celebrating American Independence! – 50 Resources on America’s Founding for Schoolchildren & Citizens

American schoolchildren need to know more about the basic history of and lessons from the American Revolution and War for Independence, including perhaps the greatest leader and hero the country has ever produced, George Washington. To do our small part to help the cause, we’re offering a variety of resources to help parents, teachers, schoolchildren, and citizens better celebrate the Fourth of July!

Why does a gender-gap persist in vaccination rates?

/
Men are more likely to die of COVID-19 than women: 13 men die…

“The Jazz Age” – 1920s America – 50 Resources for High School Students

American schoolchildren need to know more about the basics of the history of and lessons from the 1920s, which did as much as any decade to shape our modern country in the last century. To remedy this, we’re offering a variety of resources to help parents, teachers, and high schoolers:

Monarchs of the Sea – American Boats, Ships, & their Captains – 40 Resources for High School Students

In Pioneer’s ongoing series of blogs on curricular resources for parents, families, and teachers during COVID-19, this one focuses on: Celebrating American Boats, Ships, & their Captains.

Alzheimer Breakthrough Disillusionment: Confusion on FDA’s Approval of Expensive and Possibly Ineffective Drug

Hubwonk host Joe Selvaggi talks with precision medicine expert Hannah Mamuszka and Pioneer Institute's Bill Smith about the promises and pitfalls of the newly approved Alzheimer’s drug Aduhelm, and the challenges presented when new, expensive drugs of dubious benefit are introduced to the nation’s formulary.

Umesh Bhuju Seeks a Fair Deal for Immigrants, Farmers & the Environment

This week on JobMakers, Host Denzil Mohammed talks with Umesh Bhuju, owner of Zumi’s Espresso in Ipswich, Massachusetts, about how a business model based on selling nothing but fair-trade products can thrive in a world driven by profit. He describes his early experiences in his homeland of Nepal, where he witnessed child labor, and how that has shaped his pursuit of the American dream.

New York Times Best Seller Paul Reid on Winston Churchill, WWII, & the Cold War

This week on “The Learning Curve," Cara and guest co-host Kerry McDonald talk with Paul Reid, co-author, with William Manchester, of the New York Times best-selling biography of Winston Churchill, The Last Lion: Defender of the Realm, 1940-1965. Reid shares how he was enlisted to complete William Manchester’s biographical trilogy on the greatest political figure of the 20th century, which became a best-seller.